We would love for you to become a part of our community. Join our Discord to connect with us and other members!

Ticker
PAB.AU

Price
0.00
Stock movement down
-0.00 (-25.00%)
Company name
Patrys Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
6.17M
Ent value
4.62M
Price/Sales
2.10
Price/Book
1.78
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-62.50%
3 year return
-56.72%
5 year return
-32.30%
10 year return
-24.40%
Last updated: 2025-01-04

DIVIDENDS

PAB.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.10
Price to Book1.78
EV to Sales1.58

FINANCIALS

Per share

Loading...
Per share data
Current share count2.06B
EPS (TTM)-0.00
FCF per share (TTM)-0.00

Income statement

Loading...
Income statement data
Revenue (TTM)2.93M
Gross profit (TTM)2.93M
Operating income (TTM)-9.45M
Net income (TTM)-8.30M
EPS (TTM)-0.00
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)100.00%
Operating margin (TTM)-322.04%
Profit margin (TTM)-282.90%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.24M
Net receivables1.34M
Total current assets3.81M
Goodwill0.00
Intangible assets348.75K
Property, plant and equipment4.30K
Total assets4.16M
Accounts payable238.39K
Short/Current long term debt0.00
Total current liabilities688.74K
Total liabilities691.37K
Shareholder's equity3.47M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-4.50M
Capital expenditures (TTM)3.24K
Free cash flow (TTM)-4.51M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-239.11%
Return on Assets-199.38%
Return on Invested Capital-239.11%
Cash Return on Invested Capital-129.90%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.00
Daily high0.00
Daily low0.00
Daily Volume1.72M
All-time high0.51
1y analyst estimate0.12
Beta0.56
EPS (TTM)-0.00
Dividend per share-
Ex-div date-
Next earnings date21 Feb 2025

Downside potential

Loading...
Downside potential data
PAB.AUS&P500
Current price drop from All-time high-99.41%-2.61%
Highest price drop-99.41%-56.47%
Date of highest drop3 Jan 20259 Mar 2009
Avg drop from high-90.82%-11.12%
Avg time to new high538 days12 days
Max time to new high3758 days1805 days
COMPANY DETAILS
PAB.AU (Patrys Ltd) company logo
Marketcap
6.17M
Marketcap category
Small-cap
Description
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. The company dvelops Deoxymab 3E10 also called PAT-DX1 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents such as radiation and many chemotherapy drugs. In addition, it develops PAT-DX3, a full-sized antibody that has DNA-targeting properties of PAT-DX1, but different pharmaceutic properties, such as tissue distribution, pharmacokinetic profile, etc. Further, it is involved in DNA targeting, blood-brain barrier, Inhibit NETosis human therapeutic applications. Patrys Limited was incorporated in 2006 and is based in Melbourne, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found